No Access

FNN Based-Virtual Screening Using 2D Pharmacophore Fingerprint for Activity Prediction in Drug Discovery

Seloua Hadiby

Department of Computer Science, Computer Research Laboratory, Badji Mokhtar University, Annaba, Algeria

Search for more papers by this author

and

Yamina Mohamed Ben Ali

Department of Computer Science, Computer Research Laboratory, Badji Mokhtar University, Annaba, Algeria

Corresponding author.

Search for more papers by this author

https://doi.org/10.1142/S1469026822500195Cited by:1 (Source: Crossref)

Abstract

Drug discovery remains a hard field that faces from the beginning of its process to the end many difficulties and challenges in order to discover a new potential drug. The use of technology has helped a lot in achieving many goals at the lowest cost and in the shortest possible time. Machine learning methods have proven for many years their performance although their limitations in some cases. The use of deep learning for virtual screening in drug discovery allows to process efficiently the huge amount of data and gives more precise results. In this paper, we propose a procedure for virtual screening (VS) based on Feedforward Neural Network in order to predict the biological activity of a set of chemical compounds on a given receptor. we have proposed a distance interval and it divisions to describe the chemical compound by the 2D pharmacophore fingerprint. Our model was trained on a dataset of active and inactive chemical compounds on cyclin A kinase1 receptor (CDK1), a very important protein family which has a role in the regulation of the cell cycle and cancer development. The results have proven that the proposed model is efficient and comparable with some widely used machine learning methods in drug discovery.

Keywords:

Remember to check out the Most Cited Articles!
Check out these titles in artificial intelligence!

References

1. T. B. Kimber, Y. Chen and A. Volkamer, Deep learning in virtual screening: Recent applications and developments, Int. J. Mol. Sci. 22 (2021) 4435. https://doi:10.3390/ijms22094435. Crossref, Google Scholar
2. W. Patrick Walters, M. T. Stahl and M. A. Murcko, Virtual screening — An overview, Drug Discov. Today 3 (1998) 160–178. Crossref, Google Scholar
3. A. Lavecchia, Machine-learning approaches in drug discovery: Methods and applications, Drug Discov. Today 20 (2015) 318–331. Crossref, Google Scholar
4. A. Lavecchia, Deep learning in drug discovery: Opportunities, challenges and future prospects, Drug Discov. Today 24 (2019) 2017–2032. Crossref, Google Scholar
5. A. C. Massagu, M. J. Ojeda, C. Valls, M. Mulero, S. Garcia-Vallvé and G. Pujadas, Molecular fingerprint similarity search in virtual screening, Methods 71 (2015) 58–63. Crossref, Google Scholar
6. C. Rda, E. Kaufmann and A. Delahaye-Duriez, Machine learning applications in drug development, Comput. Struct. Biotechnol. J. 18 (2020) 241–252. Crossref, Google Scholar
7. S. P. Leelananda and S. Lindert, Computational methods in drug discovery, Beilstein J. Org. Chem. 12 (2016) 2694–2718. https://doi.org/10.3762/bjoc.12.267 Crossref, Google Scholar
8. E. H. B. Maia, L. C. Assis, T. A. de Oliveira, A. M. da Silva and A. G. Taranto, Structure-based virtual screening: From classical to artificial intelligence, Front. Chem. 8 (2020) 343. Crossref, Google Scholar
9. J. Vamathevan, D. Clark, P. Czodrowski, I. Dunham, E. Ferran, G. Lee, B. Li, A. Madabhushi, P. Shah, M. Spitzer and S. Zhao, Applications of machine learning in drug discovery and development, Nat. Rev. Drug Discov. 18 (2019) 463–477. Crossref, Google Scholar
10. T. Rodrigues and G. J. L. Bernardes, Machine learning for target discovery in drug development, Curr. Opin. Chem. Biol. 56 (2020) 16–22. https://doi.org/10.1016/j.cbpa.2019.10.003 Crossref, Google Scholar
11. R. Rahman, S. R. Dhruba, S. Ghosh and R. Pal, Functional random forest with applications in dose-response predictions, Sci. Rep. 9 (2019) 1–14. https://doi.org/10.1038/s41598-018-38231-w Crossref, Google Scholar
12. V. Svetnik, A. Liaw, C. Tong, J. Christopher Culberson, R. P. Sheridan and B. P. Feuston, Random forest: A classification and regression tool for compound classification and QSAR modeling, J. Chem. Inf. Comput. Sci. 43 (2003) 1947–1958. Crossref, Google Scholar
13. X. Pang, W. Fu, J. Wang, D. Kang, L. Xu, Y. Zhao, A. L. Liu and G. H. Du, Identification of estrogen receptor $α$ $α$ antagonists from natural products via in vitro and in silico approaches, Oxid. Med. Cell. Longev. 2018 (2018). Crossref, Google Scholar
14. A. M. Wassermann, H. Geppert and J. Bajorath, Application of support vector machine-based ranking strategies to search for target-selective compounds, Methods Mol. Biol. 672 (2011) 517–530. Crossref, Google Scholar
15. G. Hinselmann, L. Rosenbaum, A. Jahn, N. Fechner, C. Ostermann and A. Zell, Large-scale learning of structure-activity relationships using a linear support vector machine and problem-specific metrics, J. Chem. Inf. Model. 51 (2011) 203–213. Crossref, Google Scholar
16. J. Ma, R. P. Sheridan, A. Liaw, G. E. Dahl and V. Svetnik, Deep neural nets as a method for quantitative structure-activity relationships, J. Chem. Inf. Model. 55 (2015) 263–274. Crossref, Google Scholar
17. A. Lusci, G. Pollastri and P. Baldi, Deep architectures and deep learning in chemoinformatics: The prediction of aqueous solubility for drug-like molecules, J. Chem. Inf. Model. 53 (2013) 1563–1575. Crossref, Google Scholar
18. A. Mayr, G. Klambauer, T. Unterthiner and S. Hochreiter, DeepTox: Toxicity prediction using deep learning, Front. Environ. Sci. 3 (2016). Crossref, Google Scholar
19. G. E. Dahl, N. Jaitly and R. Salakhutdinov, Multi-task neural networks for QSAR predictions, (2014) 1–21, http://arxiv.org/abs/1406.1231. Google Scholar
20. A. Aliper, S. Plis, A. Artemov, A. Ulloa, P. Mamoshina and A. Zhavoronkov, Deep learning applications for predicting pharmacological properties of drugs and drug repurposing using transcriptomic data, Mol. Pharm. 13 (2016) 2524–2530. Crossref, Google Scholar
21. I. Wallach, M. Dzamba and A. Heifets, AtomNet: A deep convolutional neural network for bioactivity prediction in structure-based drug discovery, (2015) 1–11, http://arxiv.org/abs/1510.02855. Google Scholar
22. T. Shi, Y. Yang, S. Huang, L. Chen, Z. Kuang, Y. Heng and H. Mei, Molecular image-based convolutional neural network for the prediction of ADMET properties, Chemometr. Intell. Lab. Syst. 194 (2019) 103853. Crossref, Google Scholar
23. D. K. Duvenaud, D. Maclaurin, J. A. Iparraguirre, R. G. Bombarell, T. Hirzel, A. A. Guzik and R. P. Adams, Convolutional networks on graphs for learning molecular fingerprints, in Advances in Neural Information Processing Systems (2015), pp. 2224–2232. Google Scholar
24. C. W. Coley, R. Barzilay, W. H. Green, T. S. Jaakkola and K. F. Jensen, Convolutional embedding of attributed molecular graphs for physical property prediction, J. Chem. Inf. Model. 57 (2017) 1757–1772. Crossref, Google Scholar
25. E. J. Bjerrum, SMILES enumeration as data augmentation for neural network modeling of molecules, (2017), http://arxiv.org/abs/1703.07076. Google Scholar
26. G. Amendola and S. Cosconati, PyRMD: A new fully automated AI-powered ligand-based virtual screening tool, J. Chem. Inf. Model. 61 (2021) 3835. Crossref, Google Scholar
27. I. Mendolia, S. Contino, U. Perricone, R. Pirrone and E. Ardizzone, A convolutional neural network for virtual screening of molecular fingerprints, Lecture Notes in Computer Science, Including Subseries Lecture Notes Artificial Intelligence Lecture Notes Bioinformatics, Vol. 11751 (2019), pp. 399–409. Google Scholar